Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · IEX Real-Time Price · USD
11.19
+0.10 (0.90%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Lexeo Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Lexeo Therapeutics stock have an average target of 22.29, with a low estimate of 19 and a high estimate of 28. The average target predicts an increase of 99.20% from the current stock price of 11.19.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LXEO stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +96.60% | Jul 16, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +105.54% | Jul 15, 2024 |
| Baird | Baird | Buy Initiates $28 | Buy | Initiates | $28 | +150.22% | Jun 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +96.60% | Jun 6, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $22 → $24 | Buy | Maintains | $22 → $24 | +114.48% | Mar 12, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
765.00K
EPS This Year
-2.92
from -12.40
EPS Next Year
-3.03
from -2.92
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 4.7M | n/a | 59.9M | 337.1M |
| Avg | n/a | 765,000 | n/a | 24.3M | 116.7M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 1,285.8% |
| Avg | - | - | - | - | 379.8% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.58 | -2.18 | -1.98 | -1.47 | 0.07 |
| Avg | -2.92 | -3.03 | -3.46 | -3.80 | -2.60 |
| Low | -3.70 | -4.96 | -6.13 | -6.65 | -4.62 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.